Published in Hepatitis Weekly, February 7th, 2005
The agreement covers exclusive use of DISC-HSV and DISC-GM-CSF for preventative as well as therapeutic products in select conditions and options to obtain rights to additional indications. The agreement includes the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.